With 20.8 million children and adults, i.e. 7% of the US population suffering from diabetes, we are surely living at an ‘epicenter’ of the disease and hence both defiance and despair.
Unfortunately, an estimated only 14.6 million have been diagnosed, with 6.2 million people — nearly one-third - are unaware of their bearing the disease. To add to the prevailing problems, and the increasing trend, the painful medications or ‘jabs’ discourage many diabetics from continuing with the treatment.
But, here is a new solution to the painful anti-diabetic jabs - a new insulin pill!
Ah! So, the pill could mean an end to those painful injections for the UK’s 2 million and US’s 20.8 million diabetics, especially the young children who often fear needles.
Thanks to the Jersey-based company Diabetology for conducting this breakthrough research.
The research claims that a ‘twice-daily’ oral dose of an insulin pill, taken before breakfast and the evening meal can successfully control glucose levels in patients.
This development surely promises a ‘needle less future’ for the diabetics.
